… after market operating hours. Biocon's Biologics business … of Branded generic immunotherapy and nephrology small molecule formulations being … March 2024, the BBL (Biocon Biologics Limited) had entered into … in the earnings release. Biocon's board of …

… is in-line with Biocon Biologics’ strategy to unlock … partnership with Eris for Biocon’s Nephrology and Dermatology business … & Managing Director, Biocon Biologics Limited, said: “This strategic … with Eris for our Nephrology and Dermatology products and …

… , with Bangalore-based generics giant Biocon selling Indian branded formulations businesses … of 2023, when Biocon sold its dermatology and nephrology branded formulations businesses … employees will be transferred from Biocon to Eris. “[The collaboration]  …

… is to acquire biopharmaceutical company Biocon Biologics’ India branded formulation business … 10-year supply agreement with Biocon Biologics, ensuring the continued … transaction follows Biocon’s earlier sale of its dermatology and nephrology branded …

… that it has acquired Biocon Biologics’ Branded Formulations business … and supply of the Biocon product series for commercialisation … CEO & Managing Director, Biocon Biologics Limited, said. “It … with Eris for our Nephrology and Dermatology products and …

… partnership with Eris for Biocon’s Nephrology and Dermatology business, … part of this collaboration, Biocon Biologics will continue to … CEO & Managing Director, Biocon Biologics Limited, said, “It … with Eris for our nephrology and dermatology products and …

… of the existing partnership for Biocon’s nephrology and dermatology business announced … are expected to transition from Biocon Biologics to Eris, ensuring continuity … affordable access to lifesaving biosimilars. Biocon reported a consolidated net profit …

… the acquisition is seen, Biocon’s biosimilar business managed … Thursday, it’s parent Biocon posted a revenue from … business assets – Biocon Biologics’ Dermatology and Nephrology branded formulations business … Rs 456 crore from Biocon’s stake dilution in …

… over as group CEO of Biocon in September, declined to … debt reduction plans or timeline. Biocon's net debt … million loan to equity in Biocon Biologics by Serum, and raising … decided to divest nephrology and dermatology units of Biocon Biologics. Bains said …

… Read also: Biocon Biologics to divest dermatology, nephrology branded formulations business … integrated global biosimilars organization. Biocon Biologics has eight commercialized … oncology, immunology, and ophthalmology. Biocon Biologics has invested over USD …